Nexium (Esomeprazole) is a medication widely used to treat gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. It belongs to a class of drugs known as proton pump inhibitors (PPIs). These medications work by reducing the amount of acid produced in the stomach.
The global Nexium market is experiencing significant growth. As of 2023, the market size was valued at approximately $7.6 Bn, with a compound annual growth rate (CAGR) of 25.9%*. This growth is fueled by increasing demand for affordable healthcare products, particularly in regions like North America.
The rising prevalence of Gastroesophageal reflux disease (GERD) and other acid reflux conditions is a significant driver of the Nexium market. It is believed that approximately 35% of American men over 40 have GERD, and approximately 13% of men age 40 and above have it. Additionally, it is believed that concerns over the aging population contribute to these infections, highlighting the importance of healthcare in managing these conditions.
Healthcare is increasingly recognized as a crucial factor in managing GERD and other acid reflux conditions. With the growing awareness and focus on Nexium, more men are seeking treatment options to manage their acid reflux problems. This increased awareness also contributes to the demand for affordable healthcare products.
The growing population population with acid reflux conditions is a significant driver of the Nexium market. The aging population, particularly those over age 50, is experiencing a burden that can be compounded by factors such as infection rates, aging populations, and the aging population. The aging adult population also contributes to the demand for treatments that enhance patient wellness.
The global economic stabilization in 2028 has given theMarket a solid foundation in place of it. Theassoleystake policy,thedietary adjustment policies, and theimplementation of theGoffman and Risks ofGeriatricPsychiatrics are Key Drivers of the Nexium market.
Development of novel pharmaceutical technologies in the past 10 years has been a significant factor in the growth of the Nexium market. With the increasing geriatric population, coupled with improved healthcare infrastructure and increased spending on healthcare, the demand for innovative treatments that enhance patient wellness is expected to grow.
Gastroesophageal reflux disease (GERD) is a chronic medical condition that affects the esophageal and stomach contents. It is characterized by the occurrence of acid reflux (or reflux) symptoms such as heartburn, swallowing difficulties, and persistent acid in the mouth. These symptoms can be uncomfortable, but not always necessitate months of treatment.
The growing population with GERD is a significant driver of the Nexium market. The aging population and increasing aging age have also contributed to the demand for treatments that enhance patient wellness.
Multïve population is increasingly the primary driver of the Nexium market. It is believed that nearly 30% of American men over 40 havethis, and approximately 13% of adults age 40 and over.
The growing geriatric population has also driven the Nexium market growth. It is believed that over 35% of American men over 40 have GERD, and approximately 13% of men age 40 and over.
Zollinger-Ellison syndrome, also known as persistent esophageal dysphonia, is a medical condition characterized by the occurrence of severe gastrointestinal symptoms such as dysphagia, dysphageal discomfort, and dysphagia-like eruptions in the course of life. These symptoms can be uncomfortable, but not without risk. Understanding the risk factors associated with this condition is essential in determining the appropriate treatment approach.
Alternate Name:Pharmapure RX Esomep-EZS
Description:Nexium treats gastroesophageal reflux disease (GERD), esophagitis, and stomach ulcers. The generic version of Nexium is esomeprazole magnesium. For a supply of 30 oral tablets of Nexium Delayed-Release Capsules 40 mg is approximately $287. Take advantage of our LowerMyRx discount to receive a typical Nexium discount of up to 80% off of the retail price at participating pharmacies near you.
Dosage Form:Capsule Delayed Release
Administration Route:By mouth
Drug Class:Gastric Acid Secretion Inhibitor, Gastrointestinal Agent
Generic Available:Yes
Strength:20 MG
Warnings:Tell your doctor if you are pregnant or breastfeeding, or if you have kidney disease, liver disease, lupus, vitamin B12 deficiency, or osteoporosis. This medicine may cause the following problems: Kidney problems, including acute tubulointerstitial nephritisIncreased risk of broken bones in the hip, wrist, or spine (more likely if used several times per day or longer than 1 year)Serious skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, and drug reaction with eosinophilia and systemic symptoms (DRESS)LupusFundic gland polyps (abnormal growth in the upper part of your stomach) This medicine can cause diarrhea. Call your doctor if the diarrhea becomes severe, does not stop, or is bloody. Do not take any medicine to stop diarrhea until you have talked to your doctor. Diarrhea can occur 2 months or more after you stop taking this medicine. Tell any doctor or dentist who treats you that you are using this medicine. This medicine may affect certain medical test results. Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments. Keep all medicine out of the reach of children. Never share your medicine with anyone. Stomach pain, nausea, vomiting, weight loss, bloody or black stools
Food Warnings:Do not use esomeprazole if you are also using medicines that contain rilpivirine., Some medicines can affect how esomeprazole works. Tell your doctor if you are using any of the following: Atazanavir, cilostazol, diazepam, digoxin, erlotinib, ketoconazole, methotrexate, mycophenolate mofetil, nelfinavir, rifampin, saquinavir, St John's wort, tacrolimus, voriconazoleBlood thinner (including clopidogrel or warfarin)Diuretic (water pill)Iron supplements, This medicine can cause diarrhea. Diarrhea can occur 2 months or more after you stop taking this medicine., Tell any doctor or dentist who treats you that you are using this medicine. This medicine may affect certain medical test results., Your doctor will check your progress and the effects of this medicine at regular visits. Keep all appointments., Keep all medicine out of the reach of children.
Contcriptions for Sale & SuppliesPfizer LimitedNew Customer GuidancePrescription Required
PharmacyClinics.com is a specialty pharmaceutical company specializing in telemedicine and pharmaceutical services. We offer a wide range of pharmaceutical products, including both brand-name and generic drugs, to meet the needs of patients across a wide range of medical conditions. Our services include pharmaceutical services for both prescription and nonprescription use, and we offer pharmaceutical services to include vaccines, medical devices, and other medical services. Prescriptions are available by fax, by mail, and at participating pharmacies and specialty clinics. The PharmacyClinics.com CheckMyRx program provides access to medication for both brand-name and generic drugs. Prescriptions can be filled at any of our pharmacies or through their online pharmacies. Many pharmacies offer virtual prescription services, which allow patients to fill prescriptions without a physical visit to a physical pharmacy.
Save27%
Original price$ 21.95
Current price$ 15.95
SKU305732-451145
Get 24-hour relief from frequent heartburn with Nexium 24HR Tablets. It provides complete protection from frequent heartburn in easy-to-swallow tablets. Nexium 24HR tablets work by blocking acid directly at the source, giving you 24 hours of protection from frequent heartburn. Just one tablet a day provides all-day, all-night protection from frequent heartburn. Nexium 24HR is the #1 Selling OTC frequent heartburn brand.
is a global, convenient brand of Nexium 24HR. manufactors — including Dr.
PITTSBURGH, April 26, 2012 /PRNewswire/ -- Mylan Pharmaceuticals Inc. (Nasdaq: MYL) today announced that Mylan Pharmaceuticals Inc. (Nasdaq: MYL) has entered into a license and registration agreement (LAG) with the New Jersey State Board of Pharmacy (NHP) for a generic version of AstraZeneca's Nexium® (esomeprazole magnesium) Tablets USP (Nexium® and Prilosec®). Mylan will provide AstraZeneca with all of the generic rights in Nexium® and Prilosec® to Mylan Pharmaceuticals. Mylan Pharmaceuticals will also be able to offer AstraZeneca the exclusive rights to market the generic version of Prilosec® to Mylan Pharmaceuticals. Mylan Pharmaceuticals will be entitled to receive from AstraZeneca the exclusive rights to market the generic version of Prilosec® to Mylan Pharmaceuticals. Mylan Pharmaceuticals will also be eligible to receive the same generic rights from AstraZeneca for Prilosec® to Mylan Pharmaceuticals.
The agreement provides Mylan Pharmaceuticals with 180 days of market exclusivity for the generic Nexium® and/or Prilosec® from the NHP for all of the generic Prilosec® (esomeprazole magnesium) Tablets USP (Nexium®) and the generic Prilosec® (esomeprazole magnesium) Tablets USP (esomeprazole magnesium) Tablets (Nexium® and Prilosec®). The agreement provides Mylan Pharmaceuticals with 180 days of market exclusivity for all of the Prilosec® (esomeprazole magnesium) Tablets USP (Nexium®) and the generic Prilosec® (esomeprazole magnesium) Tablets USP (esomeprazole magnesium) Tablets (Nexium® and Prilosec®). Mylan Pharmaceuticals will be eligible to receive a 30-day supply of Prilosec® and Nexium® from AstraZeneca, while AstraZeneca will receive 180 days of exclusivity for Nexium® and Prilosec®. The agreement provides AstraZeneca with 180 days of exclusivity for Nexium® and Prilosec® from the NHP for all of the Nexium® Tablets USP (Nexium®) and the generic Prilosec® Tablets USP (esomeprazole magnesium) Tablets (Nexium® and Prilosec®). Mylan Pharmaceuticals will also be eligible to receive a 30-day supply of Prilosec® and Nexium® from AstraZeneca, while AstraZeneca will receive 180 days of exclusivity for Nexium® and Prilosec® from AstraZeneca, while AstraZeneca will receive 180 days of exclusivity for Nexium® and Prilosec® from AstraZeneca.
Prescription Required
Quantity:
Price:$47.99$47.99 per unit
Country:
Please Select... 1 from Canada $47.99 1 from Australia $47.99
The generic Nexium 40 mg is the same as the brand New Zealand product. Nexium 40 mg is manufactured by Cipla, which is located in the United States. The brand New Zealand product is manufactured by GlaxoSmithKline of Switzerland. Nexium 40 mg is available in the quantity of one tablet.
The generic Esomeprazole 40 mg is the same as the brand New Zealand product.
Buy Esomeprazole 40 mg online from Canada by visiting the website and then clicking the Buy Now button below:
Stade de France Pharmacy